Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
The Axcelis Technologies Inc (ACLS) news page on Stock Titan aggregates company announcements, industry event participation and regulatory disclosures focused on its role in the semiconductor equipment market. Axcelis describes itself as a leading supplier of enabling ion implantation solutions for the semiconductor industry, with more than 45 years of experience providing high-productivity systems and lifecycle support.
Investors and industry followers can use this page to monitor Axcelis’ updates on product launches, technology platforms and market engagement. Recent news has highlighted the introduction of the Purion Power Series+ ion implant platform for next generation power devices, including silicon carbide (SiC) power devices and superjunction architectures, as well as the GSD Ovation ES high current implanter for engineered substrates. Company releases also cover its participation in major industry events such as SEMICON Japan and the International Conference on Silicon Carbide and Related Materials (ICSCRM), where Axcelis technologists present technical work on SiC and related materials.
The feed also includes financial and corporate developments, such as quarterly results announcements, conference call schedules and Axcelis’ participation in investor conferences. A significant recent development is the all-stock merger agreement with Veeco Instruments Inc., under which Veeco is expected to become a wholly owned subsidiary of Axcelis, subject to regulatory and shareholder approvals.
By following this ACLS news page, readers can track Axcelis’ communications on its ion implantation product portfolio, aftermarket strategy, global customer engagement and planned combination with Veeco, all drawn from official press releases and SEC-referenced materials.
Axcelis (Nasdaq: ACLS) reported Q1 2026 results: revenue $199.0M, GAAP gross margin 40.5%, GAAP operating margin 4.0%, GAAP EPS $0.30 and non-GAAP EPS $0.72. The company ended the quarter with about $570M cash and reiterated 2026 revenue is expected to be relatively flat vs 2025. Axcelis expects the Veeco merger to close in the second half of 2026.
Axcelis (NASDAQ: ACLS) will participate in the Advanced Semiconductor Manufacturing Conference (ASMC) on May 11–14, 2026 in Albany, New York.
Axcelis technologists will present in the technical forum on May 13 (Session 9: Equipment Optimization) and the company is sponsoring ASMC's Opening Reception and the collocated Women in Semiconductors conference on May 14. Presentations include work on MUSIC™ for SiC MOSFET implants and high-dose boron doping analysis; Julia Okvath will join a WiS panel.
Axcelis Technologies (Nasdaq: ACLS) will release first quarter 2026 financial results after market close on May 7, 2026. The company will host a conference call the same day at 5:00 p.m. ET to discuss results.
The call will be available via webcast on the Investors page at www.axcelis.com or by registering at the provided link. Webcast replays will be available for 30 days following the call.
Axcelis (NASDAQ: ACLS) announced that the Science Based Targets initiative (SBTi) approved its greenhouse gas emissions reduction targets on March 30, 2026. Axcelis committed to net-zero by 2050 and SBTi-approved interim and long-term targets for scope 1, 2 and scope 3 emissions.
Approved targets include -65.88% scope 1 & 2 by 2030 (2022 base), -51.6% scope 3 use-of-sold-products per USD value added by 2030, -90.0% scope 1 & 2 by 2050, and -97.0% scope 3 per USD value added by 2050. Axcelis will report progress in its annual sustainability report.
Axcelis (Nasdaq: ACLS) will be Diamond Sponsor of the Compound Semiconductor Asia Conference (CS Asia) held with SEMICON China 2026 on March 24–27, 2026, in Pudong, Shanghai.
President and CEO Russell Low will deliver the opening keynote on March 24, and Worldwide Applications Director Hongchen Zhao will present on March 25. Axcelis said it will showcase the next-generation Purion Power Series+ Platform to chipmakers in China.
Hexcel (NYSE: HXL) appointed James (Jamie) Coogan as Executive Vice President and Chief Financial Officer effective May 1, 2026, reporting to Tom Gentile. Coogan succeeds interim CFO Mike Lenz, who will remain as a Senior Advisor during the transition. Coogan brings >20 years of finance experience and prior CFO roles in aerospace, defense and semiconductor industries, and holds an MBA from Yale.
Axcelis (Nasdaq: ACLS) appointed David Ryzhik as Interim Chief Financial Officer effective March 12, 2026. James Coogan will remain through April 24, 2026 to support a smooth transition. The company will engage a leading executive search firm to identify a permanent CFO. The change occurs amid Axcelis' pending merger with Veeco.
The board cited Ryzhik's knowledge of financial operations, investor relations, and his role in integration planning with Veeco as reasons for his interim appointment.
Axcelis (Nasdaq: ACLS) will participate in five investor conferences between Feb 26 and Mar 11, 2026, offering one-on-one and small group meetings with management.
Events include Susquehanna (Feb 26–27), Morgan Stanley (Mar 2–5, meetings Mar 3), Loop Capital (virtual Mar 9, in-person Mar 10), Stifel (Mar 10) and Cantor (Mar 9–11, meetings Mar 11).
Axcelis (Nasdaq: ACLS) reported Q4 2025 revenue of $238.3 million, GAAP gross margin of 47.0% and GAAP diluted EPS of $1.10. Full-year 2025 revenue was $839.0 million with GAAP EPS of $3.80. Management cited record CS&I revenue, >$100 million in free cash flow, and >$120 million returned to shareholders. Axcelis reiterated a pending merger with Veeco and provided Q1 2026 outlook of ~$195 million revenue, GAAP EPS ~$0.38, and non-GAAP EPS ~$0.71.
Axcelis Technologies (Nasdaq: ACLS) will exhibit at SEMICON Korea 2026 in Seoul, Feb 11–13, at COEX Center, Booth #D522. The company will showcase the Purion platform and introduce the next‑generation Purion H6 high current implanter.
Axcelis' presentation on ion implantation applications will be delivered by Dr. KyungWon Lee on Feb 11 at 3:15pm in Conference Room #308.